What we offer
as a differential
The organization plays a crucial role in liaising with various sectors of society, as well as public and private institutions. In doing so, it promotes and strengthens the public debate on fundamental issues for the health sector and for the development of the pharmaceutical industry in the country.
This initiative not only boosts competitiveness and innovation in the market, but also contributes significantly to the population's access to high-quality pharmaceutical treatments that are essential for public health.
This initiative not only boosts competitiveness and innovation in the market, but also contributes significantly to the population's access to high-quality pharmaceutical treatments that are essential for public health.
What is
PróGenéricos
The Brazilian Association of Generic and Biosimilar Drug Industries, founded in January 2001, is an organization that brings together the main laboratories active in the manufacture and marketing of generics and biosimilars in Brazil. Operating on a non-profit basis, its primary objective is to improve access to medicines in the country by consolidating and expanding the market for these products.
What we offer
as a differential
The organization plays a crucial role in liaising with various sectors of society, as well as public and private institutions. In doing so, it promotes and strengthens the public debate on fundamental issues for the health sector and for the development of the pharmaceutical industry in the country.
This initiative not only boosts competitiveness and innovation in the market, but also contributes significantly to the population's access to high-quality pharmaceutical treatments that are essential for public health.
This initiative not only boosts competitiveness and innovation in the market, but also contributes significantly to the population's access to high-quality pharmaceutical treatments that are essential for public health.
WANT TO KNOW MORE
ABOUT
ABOUT US?
Our Manual
Visual Identity
Team
Tiago de Moraes Vicente
CEO
Pablo Meneghel
Executive Director of
Regulatory Affairs
Rafael Barros
Financial Coordinator
Sarah Farias
Communications Coordinator
Board of Directors
TITLE
Marcus Sanchez
Chairman of the Board of Directors (EMS)
Marcelo Belapolsky
Vice-Chairman of the Board of Directors (Sandoz Brasil)
Eder Maffisoni
Board Member
(Prati Donaduzzi)
Leonora Coimbra
Board Member
(Hypera Pharma)
Walker Lahmann
Counselor
(Eurofarma)
SUBSIDIARIES
Gabriela Mallmann
Board Member
(Biosintética)
Gustavo Pagani
Advisor
(Fresenius Kabi Brazil)
Carla Muniz
Board member
(Cimed)
Georges Hajjar
Board member
(Geolab)
Juliana Megid
Board member
(Nova Química)
Supervisory Board
Associates
Gabriela Mallmann (Holder)
Vacant (alternate)
Leonora Coimbra (Holder)
Jeandré Afeche (Alternate)
Carla Muniz (Holder)
Raquel Martini (alternate)
Avinash Mishra (Holder)
Amandeep Singh
(Alternate)
Marcus Sanchez (Holder)
Juliana Megid (Alternate)
Maurizio Billi (Holder)
Walker Lahmann (Alternate)
Gustavo Pagani (Holder)
Newton Galvão (Alternate)
Georges Hajjar (Holder)
André Hajjar (Alternate)
Leonora Coimbra (Holder)
Jeandré Afeche (Alternate)
Leonora Coimbra (Holder)
Jeandré Afeche (Alternate)
Juliana Megid (Holder)
Vacant (alternate)
Eder Fernando (Holder)
Vacant (alternate)
Marcelo Belapolsky (Holder)
Milena Bourroul (Alternate)
